World Health Summit 2022

Petra Ritter is a leading expert in the field of personalized brain simulations. Her research focus is on integrating health data and complex mathematical models to discover mechanisms of brain function and dysfunction. She serves as lead of large EU digital health infrastructure projects such as EOSC Virtual Brain Cloud, eBRAIN-Health, Testing and Experimentation Facility Health AI and Robotics (TEF-Health) and EBRAINS Health Data Cloud with a total funding volume of around 100 million Euros serving the goal to enable privacy preserving collaborative research on digital human twins. Petra Ritter studied medicine at the Charite, with internships at UCSD, UCLA, Icahn School of Medicine at Mount Sinai New York, and Harvard Medical School. She has been appointed as a Johanna Quandt lifetime Professor for Brain Simulation in 2017 and since then serves as the Director of the Brain Simulation Section at the Berlin Institute of Health and Dept. of Neurology, Charité Universitätsmedizin Berlin.

Oct 18, 9:00 - 10:30 am | PD 11 - How to Achieve a Global Health Data Space

Digital Session: https://worldhealthsummit.zoom.us/j/84609762529
Meeting ID: 846 0976 2529

Breaking the data silos is essential to reshape the future of healthcare and crisis preparedness. With the growing opportunities of digital health and Artificial Intelligence (AI), we are, more than ever before, in the pole position for a Global Health Data Space that could help to treat and govern data for health as a global public good. However, across and within countries there is a stark divide in the capacity to effectively work with data. The 2021 I-DAIR Global Research Map reveals, the divide between data use leaders based in a small number of countries and the rest of the world is growing. Additionally, biases in data relating to gender, race, and age limit the universal benefit and the trust in data use.

Only when used equitably and ethically, the work with data can offer an unprecedented possibility to improve global health and well-being and achieve Universal Health Coverage (UHC) 2030. Impact at the global level will thereby only be possible with shapers and decision makers from different disciplines including from countries of relatively lower income and/or with smaller populations. With this session we wish to spark stakeholder engagement for a transparent data system that protects citizens’ data and facilitates their use for healthcare and research.

Chairs:

• Prof. Dr. Petra Ritter
  Charité - Universitätsmedizin Berlin | Berlin Institute of Health (BIH) | Professor for Brain Simulation | Germany

Heyo Kroemer assumed his role as CEO of Charité – Universitätsmedizin Berlin in September, 2019. He was previously Chairman of the Managing Board of the Göttingen University Medical Center and Dean of the Faculty of Medicine at Georg-August-Universität Göttingen. Dr. Kroemer’s medical background is in pharmacology, with a research focus on drug metabolism and transport.

Oct 16, 6:00 - 7:00 pm | Key 01 - Opening Ceremony

Digital Session: https://www.youtube.com/watch?v=-j1v-8RpgX8

The Opening Ceremony of the World Health Summit (WHS) will reflect the increasing political importance of global health and multilateralism. Federal Chancellor Olaf Scholz will open the joint WHS+WHO Summit and speak on behalf of the G7 presidency held by Germany in 2022. He will be joined by other heads of state and government, patrons, the UN and high-level speakers from different sectors reflecting on key global health developments in 2022. There will be a dialogue about the progress made in G7 and G20 as well as on the partnership between the African Union and the European Union. The Director-General of the WHO will welcome participants and outline the priorities for his second term.

Chairs:

• Prof. Axel Pries
  Charité - Universitätsmedizin Berlin | Dean | Germany
  President | World Health Summit
• Dr. Catharina Boehme
  World Health Organization (WHO) | Chef de Cabinet
• Spring Gombe
  Market Access Africa | Principal, Policy and Advocacy | Germany/Kenya

Oct 17, 4:00 -  5:30 pm | WS 19 - The Digital Tranformation of Prevention

Digital Session: https://worldhealthsummit.zoom.us/j/81126869284
Meeting ID: 811 2686 9284

Over the last years healthcare institutions have been pushed towards rapid digital transformation. The increase in the use of telehealth is one outcome of this change to health care delivery. What has not yet received the attention it deserves is that much of this shift should be directed towards strengthening prevention and supporting wellbeing including using the new tools to improve the digital engagement with patients and communities. This also includes using digital tools not only for monitoring patient’s health but also for prediction. Many patient-facing digital health products assist patients to improve outcomes through behavior and lifestyle changes, either on their own or in conjunction with existing treatments.

In the future of digital health, the next logical step would be to apply technology to support population-level disease prevention and broader preventative health and lifestyle change efforts. This implies a trust architecture so that patient data is held safely and securely. What role do hospitals play in this transformation and how can the role of hospitals change to make prevention more effective using digital tools and how can such change be initiated.

Chairs:

• Prof. Dr. Heyo Kroemer
  Charité – Universitätsmedizin Berlin | CEO | Germany

Axel Radlach Pries studied medicine at the University of Cologne. He worked as postdoctoral fellow in Cologne, at the Institute of Anaesthesiology of the German Heart Center Berlin and at the Free University Berlin where he became full professor for Physiology (1998), and head of the Charité Institute for Physiology (2001). His scientific interests include microcirculation, endothelium, tumour vasculature, blood rheology, vascular adaptation and angiogenesis. He was general secretary of the European Society for Microcirculation (ESM) and chair of the International Liaison Committee for Microcirculation. In the European Society of Cardiology (ESC), he chaired the Working Group for Coronary Pathophysiology and Microcirculation and the Council for Basic Cardiovascular Science. His awards include the Malpighi Award of the ESM, the Poiseuille Gold Medal of the International Society of Biorheology and the Silver Medal of the ESC. Since 2015, he is dean of the Charité University Medicine Berlin, 2018 and 2019 president of the Biomedical Alliance in Europe and since 2018 interim CEO of the Berlin Institute of Health.

Oct 16, 6:00 - 7:00 pm | Key 01 - Opening Ceremony

Digital Session: https://www.youtube.com/watch?v=-j1v-8RpgX8

The Opening Ceremony of the World Health Summit (WHS) will reflect the increasing political importance of global health and multilateralism. Federal Chancellor Olaf Scholz will open the joint WHS+WHO Summit and speak on behalf of the G7 presidency held by Germany in 2022. He will be joined by other heads of state and government, patrons, the UN and high-level speakers from different sectors reflecting on key global health developments in 2022. There will be a dialogue about the progress made in G7 and G20 as well as on the partnership between the African Union and the European Union. The Director-General of the WHO will welcome participants and outline the priorities for his second term.

Chairs:

• Prof. Axel Pries
  Charité - Universitätsmedizin Berlin | Dean | Germany
  President | World Health Summit
• Dr. Catharina Boehme
  World Health Organization (WHO) | Chef de Cabinet
• Spring Gombe
  Market Access Africa | Principal, Policy and Advocacy | Germany/Kenya

As the Chief Medical Officer for the UnitedHealthcare The Empire Plan, Prof. Friedrich is responsible for clinical leadership and strategic guidance associated with the health insurance plan. Prof. Friedrich serves as the point of contact for all internal and external clinical questions, quality improvement, and customer programs for the 1,1 million members of the Empire Plan. UnitedHealthcare is part of UnitedHealth Group. UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. UnitedHealth Group works with governments, employers, partners, and providers to care for 149 million people and share a vision of a value-based system of care that provides compassionate and equitable care. Prof. Friedrich is a BIH Visiting Professor for the Stiftung Charité to work on the establishment of the Charité as a national leader for machine-learning sepsis innovation and comprehensive quality data collection and management. Until recently, Prof. Marcus Friedrich was the Chief Medical Officer for the Office of Quality and Patient Safety within the New York State Department of Health. In that capacity, he worked with the clinical and administrative leadership at the New York State Department of Health to develop quality measurement and improvement programs. Prof. Friedrich worked on an ongoing collaboration of clinical providers, hospitals, and payers in a statewide multi-year medical home demonstration incorporating care and payment reform, using health data exchange to engage claims and clinical, electronic health record information. He also led the statewide sepsis campaign, public reporting on cardiac services and stroke, office-based surgery, antibiotic stewardship, prenatal care, and other programs statewide. As a result of the COVID-19 pandemic, he served at the NY State Department of Health, supporting NY State and Governor Cuomo in implementing and managing the response effort. He supported NY State medical supplies, statewide clinical operations, and provider communication to help control the virus in this capacity. He managed call centers and supported the inventory and distribution of PPE, medical equipment, drugs, and ventilators for NY State hospitals and nursing homes. Dr. Friedrich joined the Department of Health from Northwell Health, Manhasset, NY, where he worked as a Medical Director for the Northwell Health Clinical Integrated IPA (CIIPA). Dr. Friedrich received his medical degree from the University of Miami Miller School of Medicine and completed his MBA at Hagen University in Hagen, Germany. He did his residency in Internal Medicine at Northwell Lenox Hill Hospital. He completed a physician administrative fellowship at Northwell Health before becoming faculty at the North Shore University Hospital Department of Medicine. He is a practicing primary care physician providing HIV care in the Albany NY/ Capital Region community.

Oct 17, 2:00 - 3:30 pm | WS 16 - Addressing Sepsis on the Global and National Level

Digital Session: https://worldhealthsummit.zoom.us/j/81060596734
Meeting ID: 810 6059 6734

Sepsis is a global health emergency affecting approximately 50 million people each year and resulting in at least 11 million deaths worldwide. These figures represent 20% of all-cause global mortality and do not consider the added burden contributed by COVID-19 over the past two and a half years.

According to the World Health Organization, most sepsis deaths can be prevented through improved infection prevention, early recognition and management of sepsis as an emergency, in the same way a heart attack would be treated. Preventing global sepsis deaths, however, requires reinforcement of competencies on prevention, recognition and management for all health care workers and increasing sepsis awareness at all levels of society, including among lay people, policy makers and health care authorities.

Encouraging milestones in the global fight against sepsis have been the adoption of a sepsis resolution “Improving Prevention, Recognition, Diagnosis and Clinical Management of Sepsis” at the 2017 World Health Assembly and its inclusion in the agenda of the G7 Health Ministers’ Meeting in 2022.

We will address the global burden of sepsis and Antimicrobial Resistance (AMR), highlight initiatives in addressing sepsis in sub-Saharan Africa, present data on the effectiveness of increasing awareness for sepsis and prioritizing sepsis on all levels. Discuss the impact of the implementation of quality improvement measures, such as the education of health care workers in the early recognition of deteriorating patients and the availability of rapid response teams on survival.

Finally, this workshop will provide insights on the poorly recognized potential of novel therapeutic approaches.

Chairs:

• Prof. Dr. Konrad Reinhart
  Global Sepsis Alliance (GSA) | Founding President | Germany

Petra Gastmeier studied medicine in Halle and at the Universitätsmedizin Berlin –Charité. In 1985, she completed her docotrate at the Institute for Hygiene at the Universitätsmedizin Berlin –Charité. For her PhD she received the Robert Koch Award of the Humboldt University. In 1990 she became hospital hygienist at the Ernst von Bergmann Hospital in Potsdam and held a teaching position at the Institute for Hygiene of the Free University Berlin. Beginning in 1993 she also was a research assistant and later senior physician there. In 2000 she became an associated professor for hospital hygiene at the Hannover Medical School and in 2007 she transitioned to a Full-Professor for hygiene at the Universitätsmedizin Berlin – Charité. Since 2008 she is also Director of the Institute for Hygiene and Environmental Medicine of the Universitätsmedizin Berlin – Charité and heads the National Reference center for the surveillance of nosocomial infections. Professor Gastmeier is member of the board of the interdisciplinary research consortium InfectControl and holds many other offices in the scientific and medical community. She serves on advisory boards of the World Health Organization as well as in many working groups of the European Centre for Disease Prevention and Control.

Oct 18, 2:00 - 3:00 pm | WS 28 - Making the Business Case for Investing in Infection Prevention and Control in Health Care

Digital Session: https://worldhealthsummit.zoom.us/j/82818235379
Meeting ID: 828 1823 5379

The session will focus on a global perspective and the G7 countries situation related to infection prevention and control (IPC) in health care. Highlights from the joint WHO/OECD report commissioned by the G7, the recently published global reports on IPC and WASH, and the forthcoming OECD report on the economics of Antimicrobial Resistance (AMR) will be discussed in the session, providing a situation analysis on IPC in G7 countries and globally. Experts from OECD and WHO will also demonstrate the business case for investing in IPC and WASH in health facilities, for pandemic preparedness, climate resilience and ensuring that health care facilities can provide quality, equitable care. In the second part of the session the speakers, other experts and G7 countries and the European Commission representatives will discuss about lessons learned from implementation of IPC programs.

Chairs:

• Dr. Rudi Eggers
  World Health Organization (WHO) | Director for Integrated Health Service

• Paul Zubeil
  Federal Ministry of Health (BMG) | European and International Health Politics | Deputy Director-General | Germany

Is the Director of Department of Gynecology with Center for Oncological Surgery, Deputy Director of the Charité Comprehensive Cancer Center (CCCC) and Executive Faculty Member of Global Health Charité. Since several years, he is conduting and performing various global health studies and programs focussing on prevention of cervical cancer and improving women cancer management and women health in Africa. Currently his team planing an African Summer School in Morocco for medical students and young researchers.

Oct 16, 11:00 am - 12:30 | PD 01 - Europe’s Beating Cancer Plan: Catalyzing Research and Innovation for Better Outcomes Worldwide

Digital Session: https://worldhealthsummit.zoom.us/j/83395966971
Meeting ID: 833 9596 6971

In 2018, 18.1 million people around the world had cancer, and 9.6 million died from the disease. In the European Union the number of cancer cases is particularly high compared to the proportion of the EU population worldwide. In the African region the trend of cancer incidence and deaths are forecasted to rise fastest over the next two decades compared to other world regions. On top, the COVID-19 pandemic has negatively impacted cancer care through disruption of prevention and treatment, delayed diagnosis and vaccination, and poorer access to medicines.

The EU has launched Europe's Beating Cancer Plan, which emphasizes the political commitment to mobilize the EU's stakeholders in the fight against cancer. In the African region, the Organization of African First Ladies for Development (OAFLAD), promotes cancer control policies and programs through advocacy, resource mobilization and development of partnerships with all stakeholders at all levels. Comprehensive cancer control requires a whole-of-government multi stakeholder approach which maximizes the potential of new technology and knowledge by translating innovative approaches into the context of national health care systems.

The panel discussion will address global similarities and regional differences in the fight against cancer and will propose opportunities for knowledge exchange and cooperation. This will include strategies to build effective partnerships to develop sustainable platforms for sharing expertise, data, and resources and to focus on research and innovation which reflect regional priorities and needs.

Chairs:

• Prof. Dr. Jalid Sehouli
  Charité - Universitätsmedizin Berlin | Department of Gynecology | Medical Director | Germany

• Dr. Andreas Ullrich
  Charité - Universitätsmedizin Berlin | Department of Gynecology | Visiting Scientist | Germany

Andreas Ullrich, MD specialized in internal medicine, Master of Public Health, is visiting scientist since 2019 at Charité - Universitätsmedizin Berlin at the department of gynae- oncology and the center for global health. Prior he was with WHO’s cancer control program since 2001. He developed standards and guidance to Governments in cancer control planning and capacity building. As WHO adviser in global cancer policies and partnerships he has shaped WHO’s global comprehensive cancer control strategy across health agendas and sectors with specific focus on cervical an breast cancer prevention and control in low- and middle-income countries (LMIC). He is engaged in integrating women cancer control interventions into access to care opportunities such as HIV reproductive health and immunization (HPV). Developing sustainable partnerships of academia (Charité) international professional organisations and WHO is his priority to increases access to high standards of health care for women in LMIC and to strengthen health systems to be prepared for universal health coverage.

Oct 16, 11:00 am - 12:30 | PD 01 - Europe’s Beating Cancer Plan: Catalyzing Research and Innovation for Better Outcomes Worldwide

Digital Session: https://worldhealthsummit.zoom.us/j/83395966971
Meeting ID: 833 9596 6971

In 2018, 18.1 million people around the world had cancer, and 9.6 million died from the disease. In the European Union the number of cancer cases is particularly high compared to the proportion of the EU population worldwide. In the African region the trend of cancer incidence and deaths are forecasted to rise fastest over the next two decades compared to other world regions. On top, the COVID-19 pandemic has negatively impacted cancer care through disruption of prevention and treatment, delayed diagnosis and vaccination, and poorer access to medicines.

The EU has launched Europe's Beating Cancer Plan, which emphasizes the political commitment to mobilize the EU's stakeholders in the fight against cancer. In the African region, the Organization of African First Ladies for Development (OAFLAD), promotes cancer control policies and programs through advocacy, resource mobilization and development of partnerships with all stakeholders at all levels. Comprehensive cancer control requires a whole-of-government multi stakeholder approach which maximizes the potential of new technology and knowledge by translating innovative approaches into the context of national health care systems.

The panel discussion will address global similarities and regional differences in the fight against cancer and will propose opportunities for knowledge exchange and cooperation. This will include strategies to build effective partnerships to develop sustainable platforms for sharing expertise, data, and resources and to focus on research and innovation which reflect regional priorities and needs.

Chairs:

• Prof. Dr. Jalid Sehouli
  Charité - Universitätsmedizin Berlin | Department of Gynecology | Medical Director | Germany

• Dr. Andreas Ullrich
  Charité - Universitätsmedizin Berlin | Department of Gynecology | Visiting Scientist | Germany